Jennifer Audsley

Pathway and Network Analyses Identify Growth Factor Signaling and MMP9 as Potential Mediators of Mitochondrial Dysfunction in Severe COVID-19.

Ya Wang, Klaus Schughart, Tiana Maria Pelaia, Tracy Chew, Karan Kim, Thomas Karvunidis, Ben Knippenberg, Sally Teoh, Amy L Phu, Kirsty R Short, Jonathan Iredell, Irani Thevarajan, Jennifer Audsley, Stephen Macdonald, Jonathon Burcham, undefined Predict-Consortium, Benjamin Tang, Anthony McLean, Maryam Shojaei

Journal article  |  2023  |  Int J Mol Sci

Patients with preexisting metabolic disorders such as diabetes are at a higher risk of developing severe coronavirus disease 2019 ..

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.

Jennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, Wei Zhao, Claire Deleage, Elias Rosen, Mackenzie L Cottrell, Ajantha Rhodes, Ashanti Dantanarayana, Carolin Tumpach, Surekha Tennakoon, Megan Crane, David J Price, Sabine Braat, Hugh Mason, Michael Roche, Angela DM Kashuba, Peter A Revill, Jennifer Audsley, Sharon R Lewin

Journal article  |  2023  |  EBioMedicine

BACKGROUND: HIV can infect multiple cells in the liver including hepatocytes, Kupffer cells and infiltrating T cells, but whether ..

Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals

Xiao Qian Wang, Jennifer M Zerbato, Anchalee Avihingsanon, Katie Fisher, Timothy Schlub, Ajantha Rhodes, Jennifer Audsley, Kasha P Singh, Wei Zhao, Sharon R Lewin, Sarah Palmer

Journal article  |  2022  |  JOURNAL OF VIROLOGY

Co-infection with hepatitis B (HBV) and human immunodeficiency virus (HIV) increases overall and liver-related mortality. In order..

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity

Wuji Zhang, Brendon Y Chua, Kevin J Selva, Lukasz Kedzierski, Thomas M Ashhurst, Ebene R Haycroft, Suzanne K Shoffner-Beck, Luca Hensen, David F Boyd, Fiona James, Effie Mouhtouris, Jason C Kwong, Kyra YL Chua, George Drewett, Ana Copaescu, Julie E Dobson, Louise C Rowntree, Jennifer R Habel, Lilith F Allen, Hui-Fern Koay, et al.

Journal article  |  2022  |  NATURE COMMUNICATIONS

Respiratory tract infection with SARS-CoV-2 results in varying immunopathology underlying COVID-19. We examine cellular, humoral a..

Blood transcriptome responses in patients correlate with severity of COVID-19 disease.

Ya Wang, Klaus Schughart, Tiana Maria Pelaia, Tracy Chew, Karan Kim, Thomas Karvunidis, Ben Knippenberg, Sally Teoh, Amy L Phu, Kirsty R Short, Jonathan Iredell, Irani Thevarajan, Jennifer Audsley, Stephen Macdonald, Jonathon Burcham, Anthony McLean, undefined PREDICT-19 consortium, Benjamin Tang, Maryam Shojaei

Journal article  |  2022  |  Front Immunol

BACKGROUND: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2..

HIV and Aboriginal and Torres Strait Islander Performance: arguments for the place of the arts in health education

Jonathan Graffam, Jennifer Audsley, Alyson Campbell

Report  |  2021

We have compiled a community report, with the aim of making a case for the use of theatre and performance to increase awareness of..

HIV and Aboriginal and Torres Strait Islander Performance

Jonathan Graffam, Jennifer Audsley, Alyson Campbell

Report  |  2021

The project aims to argue the value and role of the arts particularly theatre and performance—in HIV prevention in Aboriginal and ..

Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19)

Jennifer M Audsley, Natasha E Holmes, Francesca L Mordant, Celia Douros, Sara E Zufan, Thi HO Nguyen, Lukasz Kedzierski, Louise C Rowntree, Luca Hensen, Kanta Subbarao, Katherine Kedzierska, Suellen Nicholson, Norelle Sherry, Irani Thevarajan, Thomas Tran, Julian Druce

Journal article  |  2021  |  INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Therapeutics for COVID-19: established and in development

Kasha P Singh, Joe Sasadeusz, Sharon R Lewin, Jennifer Audsley

Journal article  |  2021  |  MICROBIOLOGY AUSTRALIA

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first recognised in late 2019, with over 30 0..

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

Marios Koutsakos, Louise C Rowntree, Luca Hensen, Brendon Y Chua, Carolien E van de Sandt, Jennifer R Habel, Wuji Zhang, Xiaoxiao Jia, Lukasz Kedzierski, Thomas M Ashhurst, Givanna H Putri, Felix Marsh-Wakefield, Mark N Read, Davis N Edwards, E Bridie Clemens, Chinn Yi Wong, Francesca L Mordant, Jennifer A Juno, Fatima Amanat, Jennifer Audsley, et al.

Journal article  |  2021  |  CELL REPORTS MEDICINE

SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which remains ill defined. We analyzed 85 SARS-CoV-2-..